mometasone | Momat cream 0.1%, 15 g

Release form

Cream for external use.

Pharmacological action

MOMAT - local anti-inflammatory, glucocorticoid, antipruritic.

Pharmacodynamics

Mometasone is a synthetic GCS with anti-inflammatory, antipruritic, and antiexudative effects. GCS induce the release of proteins that inhibit phospholipase A2 and commonly known as lipocortins, which control the biosynthesis of inflammatory mediators such as PG and RT, by inhibiting the release of their common precursor, arachidonic acid.

Pharmacokinetics

Absorption is negligible. 8 hours after a single application to intact skin (without an occlusive dressing), about 0.4% (cream) and 0.7% (ointment) of the active substance are found in the systemic circulation. Mometasone is extensively metabolized in the liver, excreted mainly by the kidneys and in small quantities with bile. T1 / 2 is approximately 5.8 hours (ointment).

Indications

Inflammation and pruritus in dermatoses amenable to corticosteroids therapy.

Contraindications

hypersensitivity to any component of the drug or corticosteroids

rosacea, perioral dermatitis

bacterial, viral (Herpes simplex, chickenpox, Herpes zoster) or fungal infection of the skin

tuberculosis, pregnancy, skin areas long-term treatment)

lactation (use in large doses and / or for a long time)

children under 2 years of age (ointment).

Precautions: application to the skin of the face and intertriginous skin, the use of occlusive dressings, as well as the treatment of large areas of skin and / or prolonged treatment (especially in children).

Pregnancy and lactation

The safety of mometasone furoate during pregnancy and lactation has not been studied.

corticosteroids cross the placental barrier.

Long-term treatment and the use of large doses during pregnancy should be avoided due to the threat of adverse effects on fetal development.

GCS is excreted in breast milk. In the case when it is supposed to use GCS in large doses and / or for a long time, breast-feeding should be stopped.

Composition of

100 g of cream contains:

Active ingredient:

mometasone furoate 0, 1 g

Excipients:

paraffin (soft white)

beeswax white

propylene glycol monostearate

stearyl alcohol

cetomacrogol

propylene glycol

methyl parahydroxybenzene clean

Dosage and administration

Apply externally with a thin layer to the affected skin once a day.

The duration of the course of treatment is determined by its effectiveness, as well as patient tolerance, the presence and severity of side effects.

Side effects

Rarely - skin irritation and dryness, burning sensation, itching, folliculitis, hypertrichosis, acne, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin maceration, secondary infection, signs of skin atrophy, stria. In less than 1% of cases - the formation of papules, pustules.

When using external forms of corticosteroids for a long time and / or for treating large areas of the skin, or using occlusive dressings, especially in children and adolescents, side effects characteristic of systemic corticosteroids may occur, including adrenal insufficiency and Cushing's syndrome.

Overdose

Symptoms: Depression of function of hypothalamic-pituitary-adrenal system, including secondary adrenal insufficiency.

Treatment: symptomatic, if necessary - correction of electrolyte imbalance, withdrawal of the drug (with prolonged therapy - gradual withdrawal).

Storage Conditions

In a dark place at a temperature not exceeding 25 РC.

Shelf life

2 years.

Active ingredient

Mometasone

Formulation

cream

Possible product names

MOMAT 0.1% 15.0 CREAM

MOMAT 0.1% 15G. CREAM

Momat 0.1% cream d / external approx. 15g Tuba (R)

MOMAT CREAM 0.1% 15G

Momat cream 0.1% 15 g

Glenmark Farmasьjutikalz LTD, India